The gut microbiota-immune-brain axis: Therapeutic implications
dc.contributor.author | O'Riordan, Kenneth J. | en |
dc.contributor.author | Moloney, Gerard M. | en |
dc.contributor.author | Keane, Lily | en |
dc.contributor.author | Clarke, Gerard | en |
dc.contributor.author | Cryan, John F. | en |
dc.contributor.funder | Ian's Friends Foundation | en |
dc.contributor.funder | Saks-Kavanaugh Foundation | en |
dc.contributor.funder | DuPont | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | en |
dc.date.accessioned | 2025-04-23T11:15:01Z | |
dc.date.available | 2025-04-23T11:15:01Z | |
dc.date.issued | 2025 | en |
dc.description.abstract | The microbiota-gut-brain axis has major implications for human health including gastrointestinal physiology, brain function, and behavior. The immune system represents a key pathway of communication along this axis with the microbiome implicated in neuroinflammation in health and disease. In this review, we discuss the mechanisms as to how the gut microbiota interacts with the brain, focusing on innate and adaptive immunity that are often disrupted in gut-brain axis disorders. We also consider the implications of these observations and how they can be advanced by interdisciplinary research. Leveraging an increased understanding of how these interactions regulate immunity has the potential to usher in a new era of precision neuropsychiatric clinical interventions for psychiatric, neurodevelopmental, and neurological disorders. © 2025 The Authors | en |
dc.description.sponsorship | Science Foundation Ireland (SFI/12/RC/2273_P2); Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_186346/NMS2068) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 101982 | en |
dc.identifier.citation | O’Riordan, K. J., Moloney, G. M., Keane, L., Clarke, G. and Cryan, J. F. (2025) 'The gut microbiota-immune-brain axis: Therapeutic implications', Cell Reports Medicine, 6(3), 101982. DOI: 10.1016/j.xcrm.2025.101982 | en |
dc.identifier.doi | 10.1016/j.xcrm.2025.101982 | en |
dc.identifier.issn | 26663791 | en |
dc.identifier.issued | 3 | |
dc.identifier.journaltitle | Cell Reports Medicine | en |
dc.identifier.uri | https://hdl.handle.net/10468/17304 | |
dc.identifier.volume | 6 | |
dc.language.iso | en | en |
dc.publisher | Cell Press | en |
dc.relation.project | SFI/12/RC/2273_P2 | en |
dc.rights | © 2025, the Author(s). Open Access | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Adaptive immunity | en |
dc.subject | Gut microbiota | en |
dc.subject | Innate immunity | en |
dc.subject | Microbiome-gut-immune-brain axis | en |
dc.title | The gut microbiota-immune-brain axis: Therapeutic implications | en |
dc.type | Article (peer reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S2666379125000552-main.pdf
- Size:
- 4.41 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version